The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells.

Autor: Kühnel I; Institute for Molecular Medicine, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany., Vogler I; Institute for Molecular Medicine, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany., Spreu J; Institute for Molecular Medicine, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany., Bonig H; Institute for Transfusion Medicine and Immunohematology, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany.; German Red Cross Blood Service Baden-Württemberg-Hessen, Frankfurt am Main, Germany., Döring C; Dr. Senckenbergisches Institute of Pathology, Goethe University Hospital Frankfurt am Main, Frankfurt am Main, Germany., Steinle A; Institute for Molecular Medicine, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany.

Publikováno v: European journal of immunology [Eur J Immunol] 2024 Apr; Vol. 54 (4), pp. e2250318. Date of Electronic Publication: 2024 Feb 26.

Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers.

Autor: Pfeifer Serrahima J; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany., Zhang C; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany.; Partner Site Frankfurt/Mainz, German Cancer Consortium (DKTK), Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Oberoi P; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany.; Partner Site Frankfurt/Mainz, German Cancer Consortium (DKTK), Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bodden M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany., Röder J; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Arndt C; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Feldmann A; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Kiefer A; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany., Prüfer M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany., Kühnel I; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany., Tonn T; Experimental Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; Partner Site Dresden, German Cancer Consortium (DKTK), Dresden, Germany.; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East, Dresden, Germany., Bachmann M; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Partner Site Dresden, German Cancer Consortium (DKTK), Dresden, Germany.; National Center for Tumor Diseases (NCT) and Tumor Immunology, University Cancer Center (UCC) Carl Gustav Carus, TU Dresden, Dresden, Germany., Wels WS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Straße 42-44, 60596, Frankfurt, Germany. wels@gsh.uni-frankfurt.de.; Partner Site Frankfurt/Mainz, German Cancer Consortium (DKTK), Frankfurt, Germany. wels@gsh.uni-frankfurt.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. wels@gsh.uni-frankfurt.de.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany. wels@gsh.uni-frankfurt.de.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Sep; Vol. 72 (9), pp. 2905-2918. Date of Electronic Publication: 2023 Jan 23.

PI3K{gamma} regulates cartilage damage in chronic inflammatory arthritis

Autor: Hayer, S, Pundt, N, Peters, M A, Wunrau, C, Kühnel, I, Neugebauer, K, Strietholt, S, Zwerina, J, Korb, A, Penninger, J, Joosten, L A, Gay, S, Rückle, T, Schett, G, Pap, T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb4d5501e1cffb479b7de688f5bdaa6b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Oxyalkylation of Hydrophilic Black Alder Bark Extractives with Propylene Carbonate with a Focus on Green Polyols Synthesis.

Autor: Arshanitsa, Alexandr, Pals, Matiss, Godina, Daniela, Bikovens, Oskars

Publikováno v: Journal of Renewable Materials; 2024, Vol. 12 Issue 11, p1927-1948, 22p